Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T89083 | Target Info | |||
Target Name | HUMAN toll-like receptor 2 (TLR2) | ||||
Synonyms | Toll/interleukin-1 receptor-like protein 4; TIL4; CD282 | ||||
Gene Name | TLR2 | ||||
Biochemical Class | Toll-like receptor | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: (2r)-3-{[(2s)-3-Hydroxy-2-(Palmitoylamino)propyl]thio}propane-1,2-Diyl Dihexadecanoate | Ligand Info | |||||
Structure Description | Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide | PDB:2Z7X | ||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [1] |
PDB Sequence |
SLSCDRNGIC
36 KGSSGSLNSI46 PSGLTEAVKS56 LDLSNNRITY66 ISNSDLQRCV76 NLQALVLTSN 86 GINTIEEDSF96 SSLGSLEHLD106 LSYNYLSNLS116 SSWFKPLSSL126 TFLNLLGNPY 136 KTLGETSLFS146 HLTKLQILRV156 GNMDTFTKIQ166 RKDFAGLTFL176 EELEIDASDL 186 QSYEPKSLKS196 IQNVSHLILH206 MKQHILLLEI216 FVDVTSSVEC226 LELRDTDLDT 236 FHFSELSTGE246 TNSLIKKFTF256 RNVKITDESL266 FQVMKLLNQI276 SGLLELEFDD 286 CTLNGVGNFR296 ASDNDRVIDP306 GKVETLTIRR316 LHIPRFYLFY326 DLSTLYSLTE 336 RVKRITVENS346 KVFLVPCLLS356 QHLKSLEYLD366 LSENLMVEEY376 LKNSACEDAW 386 PSLQTLILRQ396 NHLASLEKTG406 ETLLTLKNLT416 NIDISKNSFH426 SMPETCQWPE 436 KMKYLNLSST446 RIHSVTGCIP456 KTLEILDVSN466 NNLNLFSLNL476 PQLKELYISR 486 NKLMTLPDAS496 LLPMLLVLKI506 SRNQLKSVPD516 GIFDRLTSLQ526 KIWLHTNPWD 536 CSCPRIDYLS546 RWLNKNSQKE556 QGSAKCSGSG566 KPVRSIICP
|
|||||
|
LEU266
4.205
MET270
3.639
LEU273
4.270
LEU282
3.388
PHE284
4.057
PHE295
4.566
ASP305
4.774
PRO306
4.103
VAL309
4.005
LEU312
3.694
ILE314
4.329
LEU317
3.893
ILE319
3.901
PHE322
3.672
TYR323
4.590
PHE325
3.580
TYR326
3.672
ASP327
3.503
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007 Sep 21;130(6):1071-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.